KR Choksey's research report on Granules India
GRANULES is expected to continue to see strong growth in FDFs with growth in new products; partially offset by continued weakness in APIs with higher channel inventory for Paracetamol APIs in regulated markets. We expect the company to clock in 14.0% and 33.3% CAGR rise in revenue and net income, respectively, over FY24- FY26E (vs. 13.4% and 30.2% CAGR rise seen over FY24-FY26E earlier).
Outlook
We apply a higher PE multiple of 26.5x (earlier 16.0x) on FY26E EPS of INR 29.0 (earlier INR 27.7) and arrive at a TP of INR 769 (earlier INR 443) and upgrade it to BUY from ACCUMULATE as the upside potential is 16.2% from the CMP.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.